Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2005 2
2006 1
2007 2
2008 2
2009 2
2010 1
2012 1
2013 1
2017 3
2018 2
2019 4
2020 5
2021 7
2022 8
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.
Du X, Tang F, Liu M, Su J, Zhang Y, Wu W, Devenport M, Lazarski CA, Zhang P, Wang X, Ye P, Wang C, Hwang E, Zhu T, Xu T, Zheng P, Liu Y. Du X, et al. Among authors: lazarski ca. Cell Res. 2018 Apr;28(4):416-432. doi: 10.1038/s41422-018-0011-0. Epub 2018 Feb 22. Cell Res. 2018. PMID: 29472691 Free PMC article.
Sunsetting B-prolymphocytic leukemia.
Abdulbaki R, Mugnaini EN, Partain J, Lazarski C, Nava VE. Abdulbaki R, et al. Among authors: lazarski c. Ann Diagn Pathol. 2022 Oct;60:152003. doi: 10.1016/j.anndiagpath.2022.152003. Epub 2022 Jul 4. Ann Diagn Pathol. 2022. PMID: 35803160 No abstract available.
OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma.
Xu Z, Murad N, Malawsky D, Tao R, Rivero-Hinojosa S, Holdhof D, Schüller U, Zhang P, Lazarski C, Rood BR, Packer R, Gershon T, Pei Y. Xu Z, et al. Among authors: lazarski c. Clin Cancer Res. 2022 Oct 3;28(19):4278-4291. doi: 10.1158/1078-0432.CCR-22-0527. Clin Cancer Res. 2022. PMID: 35736214
SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.
Conway SR, Lazarski CA, Field NE, Jensen-Wachspress M, Lang H, Kankate V, Durkee-Shock J, Kinoshita H, Suslovic W, Webber K, Smith K, Cohen JI, Burbelo PD, Zhang A, Teach SJ, Ibeh T, Delaney M, DeBiasi RL, Keller MD, Bollard CM. Conway SR, et al. Among authors: lazarski ca. Front Immunol. 2022 Jan 18;12:793197. doi: 10.3389/fimmu.2021.793197. eCollection 2021. Front Immunol. 2022. PMID: 35116027 Free PMC article.
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products.
Durkee-Shock J, Lazarski CA, Jensen-Wachspress MA, Zhang A, Son A, Kankate VV, Field NE, Webber K, Lang H, Conway SR, Hanley PJ, Bollard CM, Keller MD, Schwartz DM. Durkee-Shock J, et al. Among authors: lazarski ca. Mol Ther Methods Clin Dev. 2022 Jun 9;25:439-447. doi: 10.1016/j.omtm.2022.04.013. Epub 2022 Apr 29. Mol Ther Methods Clin Dev. 2022. PMID: 35506060 Free PMC article.
Anti-IgE effect of small-molecule-compound arctigenin on food allergy in association with a distinct transcriptome profile.
Cao M, Liu C, Srivastava KD, Lin A, Lazarski C, Wang L, Maskey A, Song Y, Chen X, Yang N, Zambrano L, Bushko R, Nowak-Wegrzyn A, Cox A, Liu Z, Huang W, Dunkin D, Miao M, Li XM. Cao M, et al. Among authors: lazarski c. Clin Exp Allergy. 2022 Feb;52(2):250-264. doi: 10.1111/cea.14048. Epub 2021 Dec 28. Clin Exp Allergy. 2022. PMID: 34757674
Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma.
Dave H, Terpilowski M, Mai M, Toner K, Grant M, Stanojevic M, Lazarski C, Shibli A, Bien SA, Maglo P, Hoq F, Schore R, Glenn M, Hu B, Hanley PJ, Ambinder R, Bollard CM. Dave H, et al. Among authors: lazarski c. Blood Adv. 2022 Jan 25;6(2):473-485. doi: 10.1182/bloodadvances.2021005343. Blood Adv. 2022. PMID: 34495306 Free PMC article. Clinical Trial.
36 results